Annual CFF
$24.00 M
-$774.73 M-96.99%
December 31, 2021
Summary
- As of February 9, 2025, TPTX annual cash flow from financing activities is $24.00 million, with the most recent change of -$774.73 million (-96.99%) on December 31, 2021.
- During the last 3 years, TPTX annual CFF has fallen by -$55.83 million (-69.93%).
Performance
TPTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$8.97 M
+$8.58 M+2166.16%
June 30, 2022
Summary
- As of February 9, 2025, TPTX quarterly cash flow from financing activities is $8.97 million, with the most recent change of +$8.58 million (+2166.16%) on June 30, 2022.
- Over the past year, TPTX quarterly CFF has stayed the same.
Performance
TPTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$14.35 M
-$367.00 K-2.49%
June 30, 2022
Summary
- As of February 9, 2025, TPTX TTM cash flow from financing activities is $14.35 million, with the most recent change of -$367.00 thousand (-2.49%) on June 30, 2022.
- Over the past year, TPTX TTM CFF has stayed the same.
Performance
TPTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TPTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -97.0% | 0.0% | 0.0% |
| 3 y3 years | -69.9% | 0.0% | 0.0% |
| 5 y5 years | -46.5% | 0.0% | 0.0% |
TPTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -95.6% | -40.2% | at low |
| 5 y | 5-year | -97.0% | at low | -98.0% | -100.6% | -98.2% | at low |
| alltime | all time | -97.0% | at low | -98.0% | -108.9% | -98.2% | -100.0% |
Turning Point Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $8.97 M(+2166.2%) | $14.35 M(-2.5%) |
| Mar 2022 | - | $396.00 K(-84.8%) | $14.72 M(-38.7%) |
| Dec 2021 | $24.00 M(-97.0%) | $2.60 M(+9.5%) | $24.00 M(-94.9%) |
| Sep 2021 | - | $2.38 M(-74.5%) | $467.57 M(+0.4%) |
| Jun 2021 | - | $9.34 M(-3.5%) | $465.59 M(-42.4%) |
| Mar 2021 | - | $9.68 M(-97.8%) | $808.39 M(+1.2%) |
| Dec 2020 | $798.74 M | $446.17 M(>+9900.0%) | $798.74 M(+126.6%) |
| Sep 2020 | - | $394.00 K(-99.9%) | $352.51 M(-35.0%) |
| Jun 2020 | - | $352.15 M(>+9900.0%) | $542.40 M(+47.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $25.00 K(-149.0%) | $366.82 M(+0.2%) |
| Dec 2019 | $366.00 M(+358.5%) | -$51.00 K(-100.0%) | $366.00 M(-17.9%) |
| Sep 2019 | - | $190.28 M(+7.8%) | $445.81 M(+74.4%) |
| Jun 2019 | - | $176.56 M(<-9900.0%) | $255.55 M(+223.4%) |
| Mar 2019 | - | -$797.00 K(-101.0%) | $79.03 M(-1.0%) |
| Dec 2018 | $79.83 M(+78.0%) | $79.76 M(>+9900.0%) | $79.83 M(>+9900.0%) |
| Sep 2018 | - | $26.00 K(-33.3%) | $71.00 K(+57.8%) |
| Jun 2018 | - | $39.00 K(+550.0%) | $45.00 K(+650.0%) |
| Mar 2018 | - | $6000.00 | $6000.00 |
| Dec 2017 | $44.85 M | - | - |
FAQ
- What is Turning Point Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Turning Point Therapeutics?
- What is Turning Point Therapeutics annual CFF year-on-year change?
- What is Turning Point Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Turning Point Therapeutics?
- What is Turning Point Therapeutics quarterly CFF year-on-year change?
- What is Turning Point Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Turning Point Therapeutics?
- What is Turning Point Therapeutics TTM CFF year-on-year change?
What is Turning Point Therapeutics annual cash flow from financing activities?
The current annual CFF of TPTX is $24.00 M
What is the all time high annual CFF for Turning Point Therapeutics?
Turning Point Therapeutics all-time high annual cash flow from financing activities is $798.74 M
What is Turning Point Therapeutics annual CFF year-on-year change?
Over the past year, TPTX annual cash flow from financing activities has changed by -$774.73 M (-96.99%)
What is Turning Point Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of TPTX is $8.97 M
What is the all time high quarterly CFF for Turning Point Therapeutics?
Turning Point Therapeutics all-time high quarterly cash flow from financing activities is $446.17 M
What is Turning Point Therapeutics quarterly CFF year-on-year change?
Over the past year, TPTX quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Turning Point Therapeutics TTM cash flow from financing activities?
The current TTM CFF of TPTX is $14.35 M
What is the all time high TTM CFF for Turning Point Therapeutics?
Turning Point Therapeutics all-time high TTM cash flow from financing activities is $808.39 M
What is Turning Point Therapeutics TTM CFF year-on-year change?
Over the past year, TPTX TTM cash flow from financing activities has changed by $0.00 (0.00%)